Speaker Profiles 30th September 2020
Shri. Jayesh Ranjan (I.A.S)
Principal Secretary - Industries & commerce (I&C), Information Technology (IT) Government of Telangana.
Jayesh Ranjan is a member of the Indian Administrative Service (IAS) of the 1992 batch working in the state of Telangana. He holds a Masters Degree in Psychology from Delhi University, a degree in Business Management from the Indian Institute of Management, Calcutta, and a Masters in Public Management from Lee Kuan Yew School of Public Policy, National University of Singapore. He has also done short courses in the University of Birmingham (on Environmental Policy Analysis), JICA training Institute, Tokyo (on lake remediation), London School of Economics (on Globalization and Leadership), Kennedy School of Government, Harvard University (in Public Policy), and Swedish Institute, Stockholm (on Sustainability and CSR). He is the All-India topper of his IAS batch of 1992. He was awarded World Banks Social Capital Visiting Scholarship in 2002 and the British Governments Gurukul Chevening Scholarship in 2005. He has done international consultancy assignments for the World Bank, UN-ESCAP, Sedatu project of Mexico, and for international NGOs working for Youth Issues like YES, Inc of the USA and NMC from Italy. He is a part of the National Pool of Trainers in Leadership constituted by the Government of India, and is involved in training and mentoring newly recruited Civil Servants.
Jayesh Ranjan is the Principal Secretary of the Industries & Commerce (I&C) and Information Technology (IT) Departments of the Government of Telangana. His assignment involves identifying opportunities of utilizing IT in various government processes, attracting new investments, and promoting digital empowerment of the citizens. His last few assignments have been in the Industrial Promotion sector as Commissioner and MD of the Industries Department, Secretary in the Tourism Promotion Department, and Vice-Chairman of the Hyderabad Urban Development Authority (HUDA), and various rural assignments in different parts of the state for over 12 years, working in diverse sectors like Tribal Development, Natural Resources Management, Poverty Alleviation and other related Social Development Sectors.
Jayesh Ranjan supports many social, cultural and charitable causes, and is on the Boards/Advisory committees of United Way (Hyderabad), Save A Childs Heart (SACH) Foundation, Young Lives India, Save the Children, Sparsh Hospice, APMAS, ML Jaisimha Sports Foundation, Hyderabad 10 K Foundation, Vijaya Foundation Trust, Ushalakshmi Breast Cancer Foundation, LSN Foundation, Tejas Foundation, Magic Bus Hyderabad, Hockey Hyderabad, World Wildlife Fund (Hyderabad chapter), Hyderabad Literary Festival and Spic-Macay.
Dr. William van't Hoff
Chief Executive Officer, NIHR Clinical Research Network
Dr William van’t Hoff is the incoming Chief Executive Officer for NIHR Clinical Research Network from April 1st 2020 . His previous post was as a Consultant Paediatric Nephrologist and Director of the NIHR Clinical Research Facility at Great Ormond Street Hospital, London. In that capacity he had strong clinical and research interests in renal tubular, metabolic and stone disorders.
He has worked in NIHR since 2006, initially leading a London based NIHR Local Research Network and later as Co-Director of the NIHR CRN Medicines for Children Research Network. Key strategic objectives were to increase the involvement of life-sciences in offering new treatment options for children and to empower children and young people in improving research (which led to Generation R). He left this role in 2016, taking up a post of NIHR CRN Clinical Director for NHS Engagement, in which he led a partnership with NIHR, HRA, R&D community and patients, working with the CQC to integrate clinical research into their assessments of hospitals.
Divya Chadha Manek
Head of Business Development (Commercial), National Institute of Health Research UK
Divya is the Head of Business Development (Commercial) for the National Institute for Health Research (NIHR) Clinical Research Network (CRN) - the research delivery arm of the NHS. Her role is to establish new and maintain existing strategic relationships with global and UK life sciences companies.
The NIHR is the nation's largest funder of health and care research, providing the people, facilities and technology for research to thrive.
Dr. Eric Lattmann
Vice President - Research, PNB Vesper Life Science Pvt Ltd.
PNB vesper is a clinical stage pharmaceutical company whose mission is to address unmet clinical needs. The company's primary focus is on the use of small molecules as neuto-peptide antagonists.
Dr. Eric holds a PhD from the university of Hannover in synthetic organic chemistry. At Aston University a collaborative programme with Prof Les Iversen was launched to design, discover and develop novel CCK antagonists as analgesics. In collaboration with Prof MJ Tisdale novel anticancer agents based on butenolides and natural products were synthesised and evaluated in vitro and in vivo. Over a decade CCK antagonists in the area of neuroscience and anticancer agents from natural sources and synthetics were prepared and tested. Consequently the idea of a CCK antagonist from a CNS drug towards an anticancer agent was promoted and realised. Dr. Eric is the principal investigator of an international research collaboration (UK, US, IN and TH) dedicated to beating CCK related cancers. Dr. Eric hold various position in academia and in industry. He was a lecturer at Aston University, professor and director at the drug discovery centre, founder of Burnley Chemical Laboratories and most recent director of pharmacology at Aston University. From August 2019 Eric is taking on the position as vice president research at PNB Vesper Life Science.
Under Dr. Lattman's direction, 5 molecules were developed for the indications of colon cancer, pancreatic cancer, IBD and pain with 2 small molecules in the pipeline undergoing clinical phase studies.
